Literature DB >> 27717035

Palatal botulinum toxin as a novel therapy for objective tinnitus in forced eyelid closure syndrome.

Thomas M Kaffenberger1, Rajarsi Mandal2, Barry M Schaitkin3, Barry E Hirsch3.   

Abstract

Objective tinnitus associated with eyelid closure is a rare clinical entity with only a few reported cases. This association previously was identified as forced eyelid closure syndrome (FECS) and involves an aberrant neural reflex between cranial nerve VII (activating the orbicularis oculi muscle) and cranial nerve V (activating the tensor tympani muscle). We present a 52-year-old Caucasian female with a 2-month history of FECS who was successfully treated with intrapalatal botulinum toxin, with full resolution of her objective tinnitus symptoms. This is the first reported use of botulinum toxin in FECS. Laryngoscope, 127:1199-1201, 2017.
© 2016 The American Laryngological, Rhinological and Otological Society, Inc.

Entities:  

Keywords:  FECS; botulinum toxin; objective tinnitus; palatal tinnitus

Mesh:

Substances:

Year:  2016        PMID: 27717035     DOI: 10.1002/lary.26191

Source DB:  PubMed          Journal:  Laryngoscope        ISSN: 0023-852X            Impact factor:   3.325


  2 in total

Review 1.  An Integrative Model Accounting for the Symptom Cluster Triggered After an Acoustic Shock.

Authors:  Arnaud J Noreña; Philippe Fournier; Alain Londero; Damien Ponsot; Nicolas Charpentier
Journal:  Trends Hear       Date:  2018 Jan-Dec       Impact factor: 3.293

2.  Behavioral Therapy for Muscular Objective Tinnitus in Forceful Eyelid Closure Syndrome (FECS): A Case Report.

Authors:  Nobumichi Maeyama; Takefumi Kamakura; Masato Nishimura; Kayoko Kawashima; Chisako Masumura; Toshimichi Yasui
Journal:  J Int Adv Otol       Date:  2021-05       Impact factor: 1.316

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.